{"count": 3, "results": [{"_id": "36999607", "pmid": 36999607, "pmcid": "PMC10049025", "title": "Metformin reverses oxidative stress-induced mitochondrial dysfunction in pre-osteoblasts via the EGFR/GSK-3beta/calcium pathway", "journal": "Int J Mol Med", "authors": ["Cao F", "Yang K", "Qiu S", "Li J", "Jiang W", "Tao L", "Zhu Y"], "date": "2023-04-01T00:00:00Z", "doi": "10.3892/ijmm.2023.5239", "meta_date_publication": "2023 Apr", "meta_volume": "51", "meta_issue": "4", "meta_pages": "", "score": 50267.207, "text_hl": "The authors previously found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can reverse the @DISEASE_Bone_Diseases @DISEASE_MESH:D001847 @@@loss of bone mass@@@ in @<m>DISEASE_Osteoporosis_Postmenopausal</m> @DISEASE_MESH:D015663 @@@post-menopausal osteoporosis@@@. ", "citations": {"NLM": "Cao F, Yang K, Qiu S, Li J, Jiang W, Tao L, Zhu Y. Metformin reverses oxidative stress-induced mitochondrial dysfunction in pre-osteoblasts via the EGFR/GSK-3beta/calcium pathway Int J Mol Med. 2023 Apr;51(4):. PMID: 36999607", "BibTeX": "@article{36999607, title={Metformin reverses oxidative stress-induced mitochondrial dysfunction in pre-osteoblasts via the EGFR/GSK-3beta/calcium pathway}, author={Cao F and Yang K and Qiu S and Li J and Jiang W and Tao L and Zhu Y}, journal={Int J Mol Med}, volume={51}, number={4}}"}}, {"_id": "40398630", "pmid": 40398630, "title": "Linagliptin-metformin combination: A novel approach to mitigate 4-vinyl cyclohexene di epoxide and dexamethasone-induced osteoporosis in mice.", "journal": "Bone", "authors": ["Nirwan N", "Jain S", "Vohora D"], "date": "2025-09-01T00:00:00Z", "doi": "10.1016/j.bone.2025.117526", "meta_date_publication": "2025 Sep", "meta_volume": "198", "meta_issue": "", "meta_pages": "117526", "score": 50264.82, "text_hl": "In this study, we explored the effect of 4-week treatment with @CHEMICAL_Linagliptin @CHEMICAL_MESH:D000069476 @@@linagliptin@@@ (a @GENE_DPP4 @GENE_13482 @@@DPP-4@@@ inhibitor) and its combination with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Osteoporosis_Postmenopausal</m> @DISEASE_MESH:D015663 @@@PMO@@@ and @DISEASE_Osteoporosis @DISEASE_MESH:D010024 @@@GIO@@@ in @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Nirwan N, Jain S, Vohora D. Linagliptin-metformin combination: A novel approach to mitigate 4-vinyl cyclohexene di epoxide and dexamethasone-induced osteoporosis in mice. Bone. 2025 Sep;198():117526. PMID: 40398630", "BibTeX": "@article{40398630, title={Linagliptin-metformin combination: A novel approach to mitigate 4-vinyl cyclohexene di epoxide and dexamethasone-induced osteoporosis in mice.}, author={Nirwan N and Jain S and Vohora D}, journal={Bone}, volume={198}, pages={117526}}"}}, {"_id": "19341939", "pmid": 19341939, "title": "Hair loss in women.", "journal": "Semin Cutan Med Surg", "authors": ["Camacho-Martínez FM"], "date": "2009-03-01T00:00:00Z", "doi": "10.1016/j.sder.2009.01.001", "meta_date_publication": "2009 Mar", "meta_volume": "28", "meta_issue": "1", "meta_pages": "19-32", "score": 50033.965, "text_hl": "When @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ is associated with @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ must be considered as treatment. ", "citations": {"NLM": "Camacho-Martínez FM. Hair loss in women. Semin Cutan Med Surg. 2009 Mar;28(1):19-32. PMID: 19341939", "BibTeX": "@article{19341939, title={Hair loss in women.}, author={Camacho-Martínez FM}, journal={Semin Cutan Med Surg}, volume={28}, number={1}, pages={19-32}}"}}]}